Advanced Biomanufacturing

AIBN researchers have secured a major grant to position lignin as a key plank in the $15 billion market for sustainable rubbers, adhesives, and coatings.

Researchers at the AIBN are harnessing bacteria to recover valuable materials and help clean up mining waste.

Organoid researchers at the AIBN have won $4.1 million MRFF grant to prove the effectiveness of epilepsy drugs made from spider venom.

With the support of the Lily Foundation, University of Cambridge Neurologist Dr Jelle van den Ameele and AIBN group leader Dr Seth Cheetham are hoping to change the fortunes of those born with a fatal condition.

Nissa Carrodus has trained countless students in the ways of the lab over her 15 years as a research assistant. Now she’s starting a PhD of her own.

The threat of climate change – the saying goes – is like a frog stuck in a rapidly heating pot of water...

Researchers from The University of Queensland are using synthetic biology to help the world’s biggest businesses transition to net zero.

A new facility at the Australian Institute for Bioengineering and Nanotechnology is set to provide researchers with cancer vaccines tailored to individual patients.

A new parcel of federal funding will help AIBN researchers produce clinical-grade mRNA products that are safer and better quality, and will potentially cost less.

By feeding waste gases like carbon dioxide, carbon monoxide, and methane to certain bacteria, Antonia Ebert is producing bioplastics that break down naturally in the environment.